DICER1 mutations in twelve Chinese patients with pleuropulmonary blastoma

Siyu Cai1, Xisi Wang2, Wen Zhao2

  • 1Center for Clinical Epidemiology & Evidence-based Medicine, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, 100045, China.

Insights

DICER1 mutations are common in Chinese pediatric pleuropulmonary blastoma (PPB) patients, similar to international frequencies. Detecting these mutations aids PPB diagnosis and awareness.

Area of Science:

  • Genetics
  • Oncology
  • Pediatrics

Background:

  • Pleuropulmonary blastoma (PPB) is a rare pediatric lung tumor.
  • DICER1 gene mutations are implicated in PPB pathogenesis.
  • Understanding mutation frequency in diverse populations is crucial.

Purpose of the Study:

  • To evaluate DICER1 mutation frequency in Chinese pediatric PPB patients.
  • To investigate the role of family history in PPB.
  • To assess the diagnostic utility of DICER1 mutation detection.

Main Methods:

  • Consecutive recruitment of 12 pediatric PPB patients.
  • Survey of family histories and genetic testing for DICER1 mutations in patients and relatives.
  • Whole-genome sequencing on selected family samples and tumor tissues.

Main Results:

  • Seven of 12 PPB patients (58%) harbored DICER1 mutations, including frameshift, nonsense, and splice-site variants.
  • Germline mutation frequency is comparable to reported rates in US, UK, and Japanese populations.
  • Two patients with DICER1 mutations had preceding lung cysts; one family had a history of thyroid diseases.

Conclusions:

  • DICER1 mutations are a significant factor in Chinese PPB pathogenesis.
  • Family history investigation and germline DICER1 mutation analysis can improve PPB diagnostic accuracy.
  • Early detection aids differential diagnosis from non-malignant lung cysts.